Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Bayer

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Oncology Reports|March 29, 2007
Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cellsLisa D Sprague, Herbert Tomaso, Karin Mengele, et al.
Physics in Medicine and Biology|December 20, 2013
Preclinical evaluation of parametric image reconstruction of [18F]FMISO PET: correlation with ex vivo immunohistochemistryXiaoyin Cheng, Christine Bayer, Constantin-Alin Maftei, et al.
Nature Communications|July 1, 2016
Eigenspectra optoacoustic tomography achieves quantitative blood oxygenation imaging deep in tissuesStratis Tzoumas, Antonio Nunes, Ivan Olefir, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiationChristine Bayer, Achim Kielow, Daniela Schilling, et al.
Molecular Imaging and Biology|July 6, 2016
Quantitative Analysis of [<sup>18</sup>F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with ImmunohistochemistryKuangyu Shi, Christine Bayer, Sabrina T Astner, et al.
Physiological Measurement|January 6, 2017
Matching the reaction-diffusion simulation to dynamic [<sup>18</sup>F]FMISO PET measurements in tumors: extension to a flow-limited oxygen-dependent modelKuangyu Shi, Christine Bayer, Florian C Gaertner, et al.
BMC Cancer|August 1, 2007
Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell linesDaniela Schilling, Christine Bayer, Anneke Geurts-Moespot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2007
PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neckChristine Bayer, Daniela Schilling, Joerg Hoetzel, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse modelsChristine Bayer, Michael E Liebhardt, Thomas E Schmid, et al.
Radiation Oncology (London, England)|June 11, 2014
Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neckMathias Gehrmann, Hanno M Specht, Christine Bayer, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Oncology Reports|March 29, 2007
Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cellsLisa D Sprague, Herbert Tomaso, Karin Mengele, et al.
Physics in Medicine and Biology|December 20, 2013
Preclinical evaluation of parametric image reconstruction of [18F]FMISO PET: correlation with ex vivo immunohistochemistryXiaoyin Cheng, Christine Bayer, Constantin-Alin Maftei, et al.
Nature Communications|July 1, 2016
Eigenspectra optoacoustic tomography achieves quantitative blood oxygenation imaging deep in tissuesStratis Tzoumas, Antonio Nunes, Ivan Olefir, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiationChristine Bayer, Achim Kielow, Daniela Schilling, et al.
Molecular Imaging and Biology|July 6, 2016
Quantitative Analysis of [<sup>18</sup>F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with ImmunohistochemistryKuangyu Shi, Christine Bayer, Sabrina T Astner, et al.
Physiological Measurement|January 6, 2017
Matching the reaction-diffusion simulation to dynamic [<sup>18</sup>F]FMISO PET measurements in tumors: extension to a flow-limited oxygen-dependent modelKuangyu Shi, Christine Bayer, Florian C Gaertner, et al.
BMC Cancer|August 1, 2007
Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell linesDaniela Schilling, Christine Bayer, Anneke Geurts-Moespot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2007
PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neckChristine Bayer, Daniela Schilling, Joerg Hoetzel, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse modelsChristine Bayer, Michael E Liebhardt, Thomas E Schmid, et al.
Radiation Oncology (London, England)|June 11, 2014
Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neckMathias Gehrmann, Hanno M Specht, Christine Bayer, et al.
Pageof 3